Clinical Trials on Healthy Adult Participants

Total 23672 results

H. Lundbeck A/S

Completed

A Study Investigating Lu AG22515 in Healthy Adults

Healthy Participants

United States
Pfizer

Completed

A Study of PF-07258669 In Healthy Adult Participants

Healthy Participants

Belgium
Arcus Biosciences, Inc.
Gilead Sciences

Completed

A Study Investigating the Safety, Absorption, and Elimination of Radioactively Labeled Etrumadenant, a New Compound in the Treatment of Cancer

Healthy Participants

Netherlands
Arcus Biosciences, Inc.

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetic Profile of Etrumadenant in Healthy Adult Participants

Healthy Participants

United States
Cerevel Therapeutics, LLC

Completed

Open-label Trial to Evaluate the Effect Carbamazepine on Darigabat Pharmacokinetics in Healthy Adult Participants

Healthy Participants

United States
Inmagene LLC

Completed

Evaluate IMG-007 in Healthy Participants

Healthy Participants

Australia
Ionis Pharmaceuticals, Inc.

Completed

A Study Comparing Two Subcutaneous Formulations: Vial and Autoinjector (AI) With Olezarsen, at Two Dose Levels, in Healthy Adult Participants

Healthy Participants

United States
ModernaTX, Inc.

Completed

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Healthy Participants

United States
Pfizer

Completed

A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men

Healthy Participants

Netherlands
Sarkana Pharma Inc

Terminated

A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants

Healthy Participants

Netherlands
Bristol-Myers Squibb

Completed

A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

Healthy Participants

United States
Amgen

Completed

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

Healthy Participants

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate

Healthy Participants

China
Taisho Pharmaceutical Co., Ltd.
Nagoya University

Completed

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Healthy Participants

Japan
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Healthy Participants

United States
H. Lundbeck A/S

Completed

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

Healthy Participants

United Kingdom
Bristol-Myers Squibb

Withdrawn

A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235

Healthy Participants

United States
Bristol-Myers Squibb

Completed

A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential

Healthy Participants

United States
Pfizer

Completed

Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)

Healthy Participants

United States
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers

Healthy Participants

Canada
Bristol-Myers Squibb

Completed

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants

Healthy Participants

United States
Tasly Pharmaceutical Group Co., Ltd

Completed

A Study of Qishenyiqi Dripping Pills in Healthy Participants

Healthy Participants

China
Eisai Co., Ltd.

Terminated

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects

Healthy Participants

Japan
Pfizer

Completed

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

Healthy Participants

United States
Bristol-Myers Squibb

Completed

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

Healthy Participants

United Kingdom
Boston Pharmaceuticals

Completed

Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of BOS161721 in Healthy Subjects

Healthy Participants

United States
Boston Pharmaceuticals

Completed

Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects

Healthy Participants

United Kingdom
Aquestive Therapeutics

Completed

Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

Healthy Participants
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.

Healthy Participants

Hong Kong
Universiti Kebangsaan Malaysia Medical Centre

Completed

Gastric Volume Estimation by Ultrasonography After Glucose Loaded Clear Fluid Ingestion in Fasted Adult

Healthy Participants

Malaysia
Turgut İlaçları A.Ş.

Completed

Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

Healthy Participants

Germany
Bristol-Myers Squibb

Completed

An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants

Healthy Participants

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants

Healthy Participants
University of Virginia

Unknown

Cerebellar Functions in Visuomotor Adaptation

Healthy Participants

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

Healthy Participants

United States
Philipps University Marburg Medical Center

Completed

Longterm Effects of Expectations on Mood

Healthy Participants

Germany
Bristol-Myers Squibb

Completed

An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

Healthy Participants

United States
Philipps University Marburg Medical Center

Unknown

The Influence of Doctor-patient Communication on Treatment Expectation, Placebo and Nocebo Response (SENSE)

Healthy Participants

Germany
Eli Lilly and Company

Completed

A Study of LY2484595 on Pharmacokinetics in Healthy Participants

Healthy Participants

United States
Takeda

Completed

A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants

Healthy Participants

China
Takeda

Completed

A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult Participants

Healthy Participants

United States
Bristol-Myers Squibb

Completed

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

Healthy Participants

United States
Eisai Co., Ltd.

Completed

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

Healthy Participants

Japan
Eisai Inc.

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730

Healthy Participants

United States
Brock Beauty Inc.
KGK Science Inc.

Completed

A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth

Healthy Participants

Canada
Bristol-Myers Squibb

Completed

A Study to Evaluate the Bioavailability of BMS-986205

Healthy Participants

United Kingdom
Mayo Clinic
SFI Research

Completed

Determining Lipid Content in Stool After Alpha-cyclodextrin (FMAT)

Healthy Participants

United States
Crucell Holland BV

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants

Healthy Participants

United States
Eisai Inc.

Completed

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

Healthy Participants

United States

3

Subscribe